- Report
- March 2024
- 194 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- August 2023
- 237 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- September 2023
- 110 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- April 2023
- 77 Pages
Asia Pacific
From €4778EUR$4,950USD£4,098GBP
- Report
- October 2022
- 127 Pages
Middle East, Africa
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- October 2022
- 131 Pages
North America
From €2027EUR$2,100USD£1,739GBP
€2896EUR$3,000USD£2,484GBP
- Report
- July 2022
- 186 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- April 2023
- 115 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- April 2023
- 117 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- November 2022
- 117 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- December 2021
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Book
- November 2008
- 496 Pages
- Book
- June 2019
- 336 Pages
The Preclinical Drug market is a segment of the Pharmaceuticals industry that focuses on the development of drugs prior to clinical trials. This includes the research and development of new drugs, as well as the testing of existing drugs for safety and efficacy. Preclinical Drug development involves a range of activities, such as the synthesis of new compounds, the evaluation of their pharmacological properties, and the assessment of their toxicity. The results of these activities are used to determine whether a drug is suitable for clinical trials.
The Preclinical Drug market is highly competitive, with a number of companies offering a range of services. These include contract research organizations (CROs), drug discovery companies, and pharmaceutical companies. Examples of companies in the market include Charles River Laboratories, WuXi AppTec, and Parexel. Show Less Read more